KIMBERLY ASHMORE: Open Payments
NPI 1104581123 · COEUR D ALENE, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$557 in 24 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $557
Food & beverage: $557
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $144 |
| PFIZER INC. | 3 | $65 |
| Merck Sharp & Dohme LLC | 2 | $50 |
| Corcept Therapeutics | 2 | $45 |
| Amgen Inc. | 2 | $37 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $25 |
| Edwards Lifesciences Corporation | 1 | $25 |
| Alnylam Pharmaceuticals Inc. | 1 | $25 |
| KYOWA KIRIN, INC. | 1 | $21 |
Products named: UBRELVY, Korlym, PREVNAR 20, EVENITY, Auvelity, GARDASIL 9, QULIPTA, MOUNJARO.
Industry payments across ID — which companies pay providers there.
